title: Interactions between von Willebrand factor and Factor VIII: where did they first meet.
authors.affiliation: Medical College of Wisconsin, Blood Research Institute, Milwaukee 53201-2178, USA.
authors.forename: R R
authors.initials: RR
authors.lastname: Montgomery
authors.forename: J C
authors.initials: JC
authors.lastname: Gill
mesh_terms: D000818:Animals; D002417:Cattle; D002881:Chromosomes, Human, Pair 12 / Q000235:genetics; D003594:Cytoplasmic Granules / Q000378:metabolism; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D005109:Extracellular Matrix / Q000378:metabolism; D005169:Factor VIII / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D005260:Female; D015316:Genetic Therapy; D005838:Genotype; D006467:Hemophilia A / Q000235:genetics / Q000628:therapy; D006801:Humans; D046911:Macromolecular Substances; D008297:Male; D051379:Mice; D008954:Models, Biological; D010911:Pituitary Neoplasms / Q000473:pathology; D010973:Platelet Adhesiveness / Q000502:physiology; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000627:therapeutic use; D014162:Transfection; D014407:Tumor Cells, Cultured; D014960:X Chromosome / Q000235:genetics; D014842:von Willebrand Diseases / Q000145:classification / Q000235:genetics / Q000628:therapy; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use
chemical_list: D046911:Macromolecular Substances; D011993:Recombinant Fusion Proteins; D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin